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The occurrence of intersex ﬁsh, where male reproductive tissues show evidence of feminization, have
been found in freshwater systems around the world, indicating the potential for signiﬁcant endocrine dis-
ruption across species in the ecosystem. Estrogens from birth control medications in wastewater treat-
ment plant efﬂuent have been cited as the likely cause, but research has shown that endocrine
disruption is not solely predictable based on hormone receptor interactions. Many other non-hormone
pharmaceuticals are found in efﬂuent at concentrations orders of magnitude higher than estrogens, yet
there is little data indicating the impacts of these other medications. The widely prescribed anti-diabetic
metformin is among the most abundant of pharmaceuticals found in efﬂuent and is structurally dissimi-
lar from hormones. However, we show here that exposing fathead minnows (Pimephales promelas) to a
concentration of metformin found in wastewater efﬂuent causes the development of intersex gonads
in males, reduced size of treated male ﬁsh, and reduction in fecundity for treated pairs. Our results
demonstrate that metformin acts as an endocrine disruptor at environmentally relevant concentrations.
 2015 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The discovery of intersex male ﬁsh, with testis containing
oocytes and other features of female gonads, in tributaries of thePotomac river in the United States (Blazer et al., 2012), rivers
throughout the United Kingdom (Jobling et al., 2009, 1998), and
watersheds downstream of wastewater treatment plants
(WWTPs) around the world (Bjerregaard et al., 2006; Tetreault
et al., 2011), are an indication of the potential presence of endo-
crine disrupting compounds (EDCs) in the aquatic environment
introduced by human activity. Full-life exposure to WWTP efﬂuent
has been shown to cause endocrine disruption in the model ﬁsh
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2011) and fathead minnow (Pimephales promelas, FHM) (Sowers
et al., 2009). Observed effects are often attributed to the presence
of estrogens from birth-control medications such as 17a-
ethinylestradiol (EE2) in efﬂuent, which have been shown to cause
intersex and reproductive decline in FHM at concentrations as low
as 1 ng L1 (Parrott and Blunt, 2005). However, some research sug-
gests that EDCs could act through other mechanisms beside classi-
cal hormone receptor pathways, such as the neuroendocrine
system and the insulin signaling axis (Diamanti-Kandarakis et al.,
2009).
Although estrogens can have impacts in the low ng L1 range,
many other pharmaceuticals are present in WWTP efﬂuent and
surface waters at concentrations orders of magnitude higher
(Blair et al., 2013a, 2013b; Chen et al., 2006). Insufﬁcient research
has been done to investigate the effects of most of these com-
pounds on organisms in the aquatic environment (Novak et al.,
2011). Despite the ubiquitous discharge of medications in WWTP
efﬂuent (Heberer, 2002; Fatta-Kassinos et al., 2011), as few as
10% of prescribed pharmaceuticals have been studied for their
environmental impacts (Brausch et al., 2012).
One of the most abundant pharmaceuticals found in recent
studies of WWTP efﬂuent and surface-waters is the anti-diabetic
drug metformin, thought to be the pharmaceutical most deposited
into the aquatic environment by mass (Oosterhuis et al., 2013) and
detected in efﬂuent at concentrations ranging from 1 to 47 lg L1
(Blair et al., 2013a, 2013b; Ghoshdastidar et al., 2014; Oosterhuis
et al., 2013; Scheurer et al., 2012). Initially introduced in the
1950s in the United Kingdom, popularity and prescription of met-
formin have continued to grow, particularly following its introduc-
tion in the United States in 1995, due to its efﬁcacy as an insulin
sensitizer, the increasing number of cases of type-2 diabetes
around the world (Viollet et al., 2012), and its recent recommenda-
tion as a therapy for prevention of type-2 diabetes (American
Diabetes Association, 2013). This biguanidine drug is excreted in
patients’ waste in its active form and, although largely converted
to byproducts in WWTPs, is still deposited into the environment
in relatively high amounts for a pharmaceutical (Oosterhuis
et al., 2013; Blair et al., 2013b), at up to 6 tons per year from
individual WWTPs in urban areas (Blair et al., 2013b).
Metformin is thought to act as an insulin sensitizer primarily
through its impacts on cellular energy balance by inhibiting com-
plex I of the electron transport chain. The resulting decrease in cel-
lular ATP levels activates the regulatory AMP kinase (AMPK),
promoting glucose uptake and breakdown as well as fatty acid oxi-
dation, thereby improving insulin sensitivity (Viollet et al., 2012).
In addition to its wide prescription as an anti-diabetic, metformin
has been indicated as a treatment in cancer as a result of its effects
on the AMPK/mTOR energy sensing pathway (Ben Sahra et al.,
2010).
Although it does not structurally resemble hormone-like com-
pounds classically identiﬁed as EDCs (Blair et al., 2000), steroid
synthesis pathways are inﬂuenced by insulin signaling, and met-
formin treatment has been shown to alter expression and activity
of enzymes involved in steroid synthesis such as cytochrome p450
CYP17 (Viollet et al., 2012). In fact, metformin has been indicated
as a treatment for instances of the endocrine disorder polycystic
ovarian syndrome (PCOS) (Tang et al., 2012). Thus, metformin’s
impacts on steroidogenesis and its use in treating PCOS suggest
its potential as a nontraditional EDC in the environment.
Our previous work showed that metformin induces transcrip-
tion of the mRNA for vitellogenin (VTG) in adult male FHM
(Niemuth et al., 2015), an egg yolk protein that is normally
expressed only in females and which is used as an indicator for
exposure to EDCs both in the laboratory and in wild populations
when measured in male ﬁsh (Jobling et al., 1998; Ankley et al.,2001; Lattier et al., 2002). We found signiﬁcantly higher levels of
VTG in adult males after four weeks of exposure to metformin at
environmentally relevant concentrations. Despite this observation,
no intersex tissue changes were observed (Niemuth et al., 2015).
However, this was a 28-d adult exposure, which may not have
represented the full effects of environmental exposure.
Development is a particularly sensitive period in the life-cycle
of an organism, including for sexual differentiation (Johns et al.,
2011), and believed to be the most sensitive stage to impacts of
toxins in the environment (Luckenbach et al., 2001). Exposure of
FHM to EE2 at 10 ng L1 during a window of 10–15 d post-hatch
(dph) was sufﬁcient to result in feminization of male gonads
observable at sexual maturity 100 dph (van Aerle et al., 2002).
However, feminization was not observed in fully mature FHM
exposed to 10 ng L1 EE2 for three weeks in adulthood
(Pawlowski et al., 2004). Thus, while our previous exposure of
adult FHM to metformin resulted only in increased VTG expression
(Niemuth et al., 2015), it is plausible that long-term metformin
exposure, including exposure during the critical period of male
sexual development (up to 90 dph in male FHM(Van Aerle et al.,
2004)), could result in more severe endocrine impacts including
intersex.
To test this hypothesis we conducted a long-term exposure of
FHM to a concentration of metformin found in WWTP efﬂuent dis-
charged into Lake Michigan (Blair et al., 2013a,b), and similar to
that found in efﬂuent elsewhere (Scheurer et al., 2012;
Ghoshdastidar et al., 2014), beginning in early development. Fish
were exposed from fry stage, 30 d post-hatch through adulthood,
about 1 year, and gonad histology, secondary sex characteristics,
growth, and reproduction from control and treated ﬁsh were
measured.
2. Materials and methods
2.1. Chemicals and exposure
Metformin (1,1-Dimethylbiguanidine hydrochloride; CAS #
1115-70-4) and ethanol (200 proof; CAS # 64-17-5) were pur-
chased from Sigma–Aldrich (St. Louis, MO). A 100 mg L1 met-
formin stock was prepared by adding 50 mg of metformin to
500 mL of 2% v/v ethanol in MilliQ ultrapure water (EMD
Millipore, Billerica, MA). Treatment tanks were dosed with
400 lL per liter of this stock to yield metformin exposure tanks
at 40 lg L1, similar to concentrations we found in WWTP efﬂuent
in Milwaukee, WI (47 lg L1) (Blair et al., 2013b) and to those
found in European (26 lg L1) (Scheurer et al., 2012) and
Canadian (10.6 lg L1) (Ghoshdastidar et al., 2014) efﬂuents.
Control tanks were dosed with 2% v/v ethanol in MilliQ ultrapure
water at 400 lL per liter. Tank water used for this study was ﬁl-
tered and dechlorinated at the UW-Milwaukee School of
Freshwater Sciences (Milwaukee, WI). Standard metrics (e.g.
ammonia, pH, nitrate) were collected weekly and were within nor-
mal parameters.
Water samples from tanks were analyzed for metformin by
LC–MS/MS at the Wisconsin State Lab of Hygiene (Madison, WI).
Metformin has been shown to be stable in aqueous solution at
temperatures from 30 to 70 C, degrading only an estimated 10%
over a period of more than 8 d, even at elevated temperatures
(Sharma et al., 2010). Metformin is also highly water soluble, with
a logP octanol/water of 1.43 (Chou, 2000). Thus one would not
expect to see a signiﬁcant reduction in metformin concentrations
due degradation or adsorption over the 3–4 d between water
changes, and indeed measured metformin concentrations in our
tanks did not decline signiﬁcantly over the period between water
changes, being 38 ± 4 lg L1 (N = 4) on Day 0 and 40 ± 6 lg L1
(N = 3) on Day 3.
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in the Klaper lab at the UW-Milwaukee School of Freshwater
Sciences (Milwaukee, WI). Thirty days post-hatch, fry were divided
into 6 tanks of 40 individuals per tank. Three tanks were dosed
with metformin at 40 lg L1 and three were dosed with vehicle
alone (giving 3 replicates of 40 ﬁsh each for both control and met-
formin treatment). Fish were kept on a 16:8 light: dark cycle and
exposed continuously throughout the experiment by static
renewal every fourth and seventh day. Fry were fed freshly
hatched Artemia salina (Ocean Star International, Snowville, UT)
in the morning and ground Tetramin tropical ﬁsh food (Tetra,
Blacksburg, VA) in the afternoon for 30 d. After these ﬁrst 30 d, ﬁsh
were fed Tetramin tropical ﬁsh food twice daily for 290 d, at which
point clear males and females were distinguishable.
Upon completion of this initial 320-d group exposure, 36 pairs
of ﬁsh (18 control: 18 metformin-treated) were used for reproduc-
tive assays. As FHM are group spawners, 6 adult male–female pairs
were separated out from each exposure tank to identify individual-
pair fecundity. Individual pairs were each placed into a compart-
ment of a new spawning tank, with 3 pairs in each spawning tank
separated from each other by clear porous dividers. The exposure
regimen for control and metformin treatment was continued in
spawning tanks.
After segregation of pairs for fecundity studies, all ﬁsh were fed
frozen Artemia salina (San Francisco Bay Brand, Newark, CA) in the
morning and Tetramin tropical ﬁsh food in the afternoon for the
remainder of the experiment. Mating pairs were exposed for an
additional 40 d after splitting. Eggs from each FHM pair were
counted daily, beginning the day subsequent to splitting.
Remaining ﬁsh were exposed for an additional 45 d post-split. In
all, mating pairs were exposed for a total of 360 d (ﬁnal N: control
pairs = 17, metformin-treated pairs = 17); remaining ﬁsh were
exposed for a total of 365 d (ﬁnal N: control males = 8, control
females = 54, metformin-treated males = 15, metformin-treated
females = 45).
At the end of each respective exposure period, ﬁsh were
euthanized in dechlorinated water containing MS-222 (Ethyl
m-Aminobenzoate Methanesulfonate; CAS# 886-86-2; MP
Biomedicals, Santa Ana, CA) buffered with sodium bicarbonate
(CAS# 144-55-8; Sigma–Aldrich, St. Louis, MO) each at
200 mg L1. Each ﬁsh was weighed, measured, and photographed
for future reference. Condition factor (K) for each ﬁsh was calcu-
lated using Fulton’s condition factor, K = 100 ⁄ (W/L3), with weight
(W) in g and length (L) in cm. Secondary sex characteristics of male
fathead minnows were scored on a 0–9 scale using the method of
Dammann et al. (2011), summing scores for tubercles (0–3), dorsal
pad (0–3), and banding (0–3) for each ﬁsh; 0 being absent and 3
being pronounced. One gonad from each ﬁsh was collected in a his-
tology cassette and immersed in ﬁxative as described below.
2.2. Histology
For mating pairs and remaining ﬁsh, upon sacriﬁce gonad tis-
sues from each male and female ﬁsh were placed in histology cas-
settes and immersed in Bouin’s ﬁxative (Sigma Aldrich, St Louis,
MO) overnight (control male N = 25, metformin-treated male
N = 31, control female N = 64, metformin-treated females N = 55).
Cassettes were transferred to 50% ethanol for 48 h to destain and
then stored in 70% ethanol. Preserved tissues were parafﬁn-em-
bedded, sectioned, and H&E stained by Histology Tech Services
(Gainesville, FL).
Scoring of male tissues for intersexuality was performed on a
0–7 scale using the method of Jobling et al. (1998), illustrated in
Fig. 1: (a) normal male testis, score of 0; (b) intersex score of 2,infrequent perinucleolar follicles (PNF) scattered throughout
otherwise normal testis; (c) score of 3, frequent PNF scattered
throughout testis; (d) score of 4, frequent PNF and possibly cortical
alveolar oocytes (CAO) clumping throughout testis; (e) score of 5,
less than 50% of testis is composed of PNF, CAO, and possibly also
early or late vitellogenic oocytes (EVO, LVO); (f) score of 6, >50% of
testis composed of PNF, CAO, EVO, LVO, and possibly mature
oocytes; (g) score of 7, 100% conversion of gonad to oocytes of
varying stages.2.3. Statistics
Because of the nested design of our experimental setup, data
were analyzed using models to test for effects of treatment as well
as any possibly confounding tank effect, in which apparent differ-
ences between treatments would be driven by ﬁsh in a single tank.
No signiﬁcant tank effect was found for any of the metrics reported
in this study (p > 0.05). For normally distributed data (weight,
length, and condition factor), a two-way nested ANOVA was
applied to determine signiﬁcance of any tank or treatment effects.
For non-normal, ordinal data (male histology and sex scores) a
generalized linear model (GLM) for ordinal data was employed to
determine tank and treatment effects. Cumulative clutch number
per pair were analyzed using a general linear model for repeated
measures. Clutch size data were analyzed using a GLM for
Tweedie (1.5) distributed data. Percent intersex was compared
between treatments using a Student’s t-test for independent sam-
ples, treating each replicate tank as an independent sample.
Correlations between data sets were determined using linear
regression analysis. Outliers were removed and all analyses per-
formed using SPSS v22 for Mac.3. Results
3.1. Histology
Metformin-exposed male FHMs had a signiﬁcant occurrence of
intersexuality, with an average score of 0.2 for control males and
an average score of 3.8 for treated males (Fig. 2, panel a). There
was a signiﬁcant difference in the percent of intersex ﬁsh per treat-
ment (histology score >0), 13% for controls versus 84% for met-
formin-treated males (Fig. 2, panel b). Fig. 1 panels a through g
demonstrate the morphology of normal male testis and differing
degrees of intersexuality observed in metformin-exposed male
ﬁsh. Fig. 1, panel a (score of 0) is representative of normal testis
observed in control male ﬁsh. Fig. 1, panel d (score of 4) is repre-
sentative of the average score observed in treated male gonad, in
which oocytes including perinucleolar follicles and primary
oocytes occur frequently throughout testicular tissue. Sections
from exposed male ﬁsh ranged in intersexuality from histologically
normal testis (score of 0, seen in 5 of 31 ﬁsh; Fig. 1a) up to gonad
sections that were entirely oocytes (score of 7, seen in 5 of 31 ﬁsh;
Fig. 1g). No histological differences were observed in female gonad
sections.3.2. Size and condition factor
We also observed signiﬁcant differences in weight and condi-
tion factor for metformin-treated males (two-way nested
ANOVAs, weight: p = 0.011, df = 1, F = 18.596; condition factor:
p < 0.001, df = 1, F = 69.221), with mean weights of 4.0 ± 0.2 g and
3.1 ± 0.1 g and condition factors of 1.51 ± 0.04 and 1.34 ± 0.04 for
control and treated males respectively. No signiﬁcant differences
(a) 
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Fig. 1. Scoring of FHM male gonad histology. Representative male gonad histology slides: (a) normal male testis, score of 0, as seen in a control male; (b) intersex score of 2,
infrequent perinucleolar follicles (PNF) scattered throughout otherwise normal testis, here in an exposed male ﬁsh; (c) score of 3, frequent PNF scattered throughout testis,
seen in an exposed male; (d) score of 4, frequent PNF and possibly cortical alveolar oocytes (CAO) clumping throughout testis; (e) score of 5, less than 50% of testis is
composed of PNF, CAO, and possibly also early or late vitellogenic oocytes (EVO, LVO); (f) score of 6, >50% of testis composed of PNF, CAO, EVO, LVO, and possibly mature
oocytes (MSO); (g) stage 7, 100% conversion of gonad to oocytes of varying stages.
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ments for female minnows (two-way nested ANOVAs: p > 0.05).
3.3. Reproduction
Signiﬁcant differences were also found for cumulative clutches
laid per mating pair over time between control and metformin-
treated minnows, with signiﬁcantly fewer clutches for met-
formin-exposed pairs (Fig. 3a). Mean clutch size per pair also
showed signiﬁcant differences between control and metformin-
treated ﬁsh, with signiﬁcantly smaller clutches for treated ﬁsh
(Fig. 3b). Importantly, treated pairs with males showing intersex
in histology still produced eggs, including the 3 treated pairs withmales having an intersex gonad histology score of 7 (complete con-
version to ova, Fig. 1 panel g) each producing a single clutch with a
mean of 140 ± 90 eggs over the course of observation.
3.4. Correlations between endpoints
A small but signiﬁcant negative correlation was found between
male intersex histology score and clutch number for mating pairs
(linear regression: R2 = 0.199, b = 0.4, p = 0.013, df1 = 1, df2 = 28,
F = 6.967). A similar negative correlation was also found between
male intersex score and clutch size (R2 = 0.138, b = 9.250,
p = 0.044, df1 = 1, df2 = 28, F = 4.465). No clear correlation was
found between size (weight, length, condition factor) and
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
Control Met-treated 
%
 in
te
rs
ex
 
Treatment  
a 
b 
0 
1 
2 
3 
4 
5 
6 
7 
Control Met-treated 
Av
er
ag
e 
sc
or
e 
(in
te
rs
ex
ul
ai
ty
, 0
-7
) 
Treatment 
a 
b 
(a) (b) 
Fig. 2. Intersex scoring for histological sections of gonad from control males and
FHM males exposed to 40 lg L1 metformin. (a) Intersex histology scores (0–7) for
males from control and metformin-treated groups. Includes scores for males from
mating pairs (exposed 360 d) and remaining males (exposed 365 d). Error bars
represent SEM. N=: control males, 25; treated males, 31. Metformin-treated males
were found to have a signiﬁcantly higher intersexuality score (generalized linear
model for ordinal numbers: p < 0.001, df = 1, v2 = 34.265). (b) Percent of ﬁsh
showing intersex (intersex histology score > 0) for control and metformin-treated
males. Error bars represent SEM. N=: control tanks, 3; metformin-treated tanks, 3.
Males frommetformin-treated tanks had a signiﬁcantly higher incidence of intersex
(t-test: p < 0.001, df = 4, t = 21.578).
42 N.J. Niemuth, R.D. Klaper / Chemosphere 135 (2015) 38–45reproductive output (clutch size, clutches per pair) for male or
female minnows (p > 0.05).3.5. Secondary sex characteristics
In addition, metformin-treated males had a decreased sec-
ondary sex score when compared to control males, however this
was not statistically signiﬁcant (Fig. 4, panel a). Total score for each
ﬁsh was based on the sum of three scores: tubercles (0–3), dorsal
pad (0–3), and banding (0–3). Importantly, treated males with an
intersex gonad histology score as high as 6 (>50% testis-ova;0 
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Fig. 3. Reproductive output for control and 40 lg L1 metformin-treated FHM pairs. (a) C
Error bars represent SEM. N=: controls pairs, 17; treated pairs, 14. Metformin-treated pa
model for repeated measures: p = 0.031, df = 1, F = 5.167). (b) Mean clutch size per pair o
represent SEM. N=: control pairs, 17; treated pairs, 14. Mean clutch size was signiﬁcan
distributed data: p = 0.011, df = 1, v2 = 6.419).Fig. 1, panel f) had a secondary sex score of 9 (Fig. 4, panel c), hav-
ing pronounced tubercles, dorsal pad, and banding while having
signiﬁcant testis-ova (see Fig. 4, panel b for comparison to control).4. Discussion
Our results demonstrate that metformin, which has recently
been found to be a major emerging contaminant in wastewater
and surface waters, has a signiﬁcant impact on the reproductive
system of FHMs and can cause intersex in male ﬁsh at concentra-
tions emerging from WWTPs. Full life-cycle metformin exposure
resulted in signiﬁcant induction of testis-ova in male gonad
(Fig. 2), a condition seen in ﬁsh in freshwater systems around the
globe. The high concentration of this compound found in WWTP
efﬂuent and watersheds worldwide warrants further investigation
of the impacts that this emerging contaminant may have on ﬁsh
populations.
This is the ﬁrst study to look at the endocrine-disrupting effects
of full life-cycle exposure to metformin in ﬁsh. Our previous study,
exposing fully-grown FHM in a 28-d chronic exposure to levels of
metformin found in WWTP efﬂuent, found a signiﬁcant upreg-
ulation of VTG mRNA in livers of metformin-treated adult males,
indicating possible endocrine disruption, but no histological or
reproductive effects were seen (Niemuth et al., 2015). The current
study reveals impacts on reproduction and gonad histology when
FHM are exposed for a full life-cycle beginning in early develop-
ment. This work further demonstrates the need to consider more
than chronic adult assays for the study of impacts on reproduction.
Moreover, our results demonstrate the need to investigate what
portion of the life-cycle is responsible for these impacts of met-
formin exposure in vertebrates.
Fish are known to be signiﬁcantly more sensitive to EDCs in
early development, particularly during sexual differentiation
(Johns et al., 2011), which is not completed in FHM males until
90 d post-hatch (Van Aerle et al., 2004). Although metformin
may not be the only compound in efﬂuent that can cause endocrine
disruption, histological changes found in this study (Fig. 1) resem-
ble those seen in studies with FHM (Sowers et al., 2009) and roach
(Rutilus rutilus) (Lange et al., 2011) exposed for a full life-cycle to
WWTP efﬂuent, as well as those found in ﬁsh downstream of
WWTPs (Jobling et al., 2009, 1998; Blazer et al., 2012).35 
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Fig. 4. Scoring of secondary sex characteristics for control males and FHM males
exposed to 40 lg L1 metformin. (a) Sex scores (0–9) for males from control and
metformin treatment groups. Combines scores for males from mating pairs
(exposed 360 d) and remaining males (exposed 365 d). Error bars represent SEM.
N=: control males, 17; treated males, 30. Metformin-treated males had a lower
score, but not signiﬁcantly (generalized linear model for ordinal numbers:
p = 0.135, df = 1, v2 = 2.233). (b) A control male with a secondary sex score of 9
and a gonad histology score of 0. (c) A metformin-treated male with a secondary sex
score of 9 and a gonad histology score of 6.
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centrations in watersheds (in the ng to lg L1 range when it has
been measured), and often at orders of magnitude higher concen-
trations than known EDCs such as EE2 (Scheurer et al., 2012;
Oosterhuis et al., 2013; Blair et al., 2013a; Ghoshdastidar et al.,
2014). EE2 has endocrine disrupting effects at concentrations in
the single ng L1 range and is found in efﬂuent at 1–62 ng L1
and in surface waters at up to 5 ng L1 (Pawlowski et al., 2004).
Metformin is found in efﬂuent at 1–47 lg L1 and in surface waters
at 12 ng L1 to 3 lg L1 throughout North America and Europe
(Blair et al., 2013a,b; Ghoshdastidar et al., 2014; Oosterhuis et al.,
2013; Scheurer et al., 2012). The data presented here and in our
previous work (Niemuth et al., 2015), exposing FHM to a concen-
tration of metformin found in efﬂuent (40 lg L1), demonstrate
the potential endocrine disrupting effects of metformin. While
the estrogenic potency of metformin likely differs from knownEDCs such as EE2 (and remains to be determined), the widespread
detection of this compound in WWTP efﬂuent and freshwater sys-
tems highlights the need to determine the potential impacts of this
compound in wild ﬁsh populations at environmental
concentrations.
Effects of metformin on gonadal development have also been
documented in at least one study in mammals, with altered tes-
ticular development in progeny of mice administered metformin
during pregnancy (Tartarin et al., 2012). Studies of the endocrine
disrupting effects of metformin are important because it currently
is being considered as a treatment for gestational diabetes (Feig
and Moses, 2011). Importantly, metformin is known to readily
cross the placenta, and has been detected in cord plasma at
upwards of 800 lg L1, 67.5% of the concentration measured in
maternal plasma and 20 times the concentration used in the pre-
sent study (Charles et al., 2006). These ﬁndings, taken together
with the signiﬁcant development of intersex in male ﬁsh seen here,
recommend further research into the potential impacts of met-
formin on vertebrate development.
Changes in gonad morphology have obvious implications for
reproduction, but changes in size may also have reproductive
impacts in ﬁsh. Metformin treated males were signiﬁcantly smaller
than their control counterparts, and metformin-treated pairs pro-
duced signiﬁcantly fewer clutches than controls (Fig. 3). As in this
study, impacts on size and fecundity were also observed in FHM
exposed for a full life-cycle to EE2, a synthetic estrogen used in oral
contraceptives (Länge et al., 2001). Female length has been shown
to be correlated with fecundity in certain ﬁsh species (Koops et al.,
2004), and, in FHM, mating pairs with males of larger size relative
to females have been shown to be more reproductively successful
(Pollock et al., 2008). Although treated males were smaller in this
study, no signiﬁcant correlation was found between fecundity
and size. We found a small but signiﬁcant negative correlation
between male gonad intersex histology score and fecundity, mea-
sured as clutch size and clutch number. However, the small size of
this correlation indicates that gonad histology may not be a good
predictor of reproductive output. The implications of these results
are that, while size-based health metrics such as condition factor
may be a good indicator of fecundity in healthy wild ﬁsh pop-
ulations, in environmental conditions where ﬁsh are exposed to
EDCs (and metrics such as size may be confounded), exposure
effects such as changes in gonad histology may not be ideal predic-
tors of reproductive output.
Interestingly, metformin-exposed males with high intersex
gonad histology scores still displayed high secondary sex charac-
teristics (as illustrated in Fig. 4). In addition, mating pairs with
these males were still able to produce eggs, even in cases where
histology showed completely intersex testis. These results suggest
that disruption is not the result of upstream changes to
steroidogenesis, a conclusion that accords with the results of our
previous 28-d study (Niemuth et al., 2015). We have suggested
that metformin may impact endocrine pathways through its
impacts on insulin signaling (Niemuth et al., 2015). However, the
exact mechanism by which metformin may act as an EDC remains
to be elucidated.
The U.S. Environmental Protection Agency currently uses a
combination of high throughput in vitro and short-term in vivo
assays to determine the endocrine disrupting effects of chemicals
(U.S. Environmental Protection Agency, 2012). However, budgetary
and ethical considerations have resulted in a push towards
increased and even exclusive use of in vitro and in silico assays
to screen for potential EDCs (U.S. Environmental Protection
Agency, 2011). These assays rely on binding of chemicals to hor-
mone receptors and similarity of chemicals to known EDCs, in par-
ticular estrogen mimics (Rotroff et al., 2013; Zang et al., 2013).
Metformin, because biguanidines do not structurally resemble
44 N.J. Niemuth, R.D. Klaper / Chemosphere 135 (2015) 38–45known hormone mimics, likely would not be detected as an EDC in
in vitro or in silico assays. While hormones such as EE2 are the
classical EDCs and the focus of much research, the work presented
here indicates a need to broaden our investigations of potential
EDCs and predictive models of what are important pathways
beyond traditional hormone receptor and response assays being
developed for high throughput screening.
Overall the research presented here demonstrates that met-
formin should be considered a compound of concern. Given its
environmental persistence and presence worldwide (Scheurer
et al., 2012; Blair et al., 2013a), this compound merits further
research on its potential environmental impacts as well as its
impacts on vertebrate development more generally and should
be added to the list of potential EDCs.Acknowledgements
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